HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
Carcinogenesis, 07/11/2012
Liu Y et al. – The study identify XPA as a novel target for regulation by HIF1α whose modulation could impact lung cancer therapy.



